Darrell S. Freeman Sr. - 01 Jun 2022 Form 4 Insider Report for CROSS COUNTRY HEALTHCARE INC (CCRN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Jun 2022, 17:57:17 UTC
Prior SEC filing
04 Jan 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Darrell S. Freeman, Sr.

Key filing fact

Darrell S. Freeman Sr. filed Form 4 for CROSS COUNTRY HEALTHCARE INC (CCRN) on 02 Jun 2022.

Key facts

  • This page summarizes Darrell S. Freeman Sr.'s Form 4 filing for CROSS COUNTRY HEALTHCARE INC (CCRN).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Jun 2022, 17:57.

Change

  • Previous filing in this sequence was filed on 04 Jan 2022.
  • Current net transaction value: -$45,119.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CCRN transaction

Common Stock

Award

Transaction value
$0
Shares
+7,201
Change %
+13%
Price
$0.000000
Shares after
63,848
Date
01 Jun 2022
Ownership
Direct
Footnotes
F1
CCRN transaction

Common Stock

Tax liability

Transaction value
$45,119
Shares
-2,599
Change %
-4.1%
Price
$17.36
Shares after
61,249
Date
01 Jun 2022
Ownership
Direct
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These restricted shares of common stock will vest June 1, 2023.

Footnote F2

These shares were withheld to satisfy Mr. Freeman's tax withholding obligation for restricted stock which vested on June 1, 2022.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .